W.O.M. World of Medicine AG

EANS-News: W.O.M. World of Medicine AG
Business figures 2009: 3.3% return on sales before taxes, despite decline in sales

@@start.t1@@--------------------------------------------------------------------------------   Corporate news transmitted by euro adhoc. The issuer/originator is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

Financial Figures/Balance Sheet

Berlin (euro adhoc) - The stock-listed medical device technology manufacturer W.O.M. WORLD OF MEDICINE AG achieved a 3.3% return on sales before taxes for fiscal year 2009 (last year: 14.7%), despite a decline in sales of 14.0%.

"Against the backdrop of such a precarious and challenging market environment as well as targeted investments in more development activities, this year's earnings development is indeed satisfactory," says Peter P. Wiest, CEO of WORLD OF MEDICINE. "The reluctance to invest was especially palpable in the US market. Asia showed the greatest level of stability."

Our cash and cash equivalents of EUR7.3 million and our equity ratio of 82.6% not only ensure our financial independence, they also offer us sufficient leeway to invest in market opportunities arising in the short-term. Our goal is to achieve sales growth in the low to mid- single-digit range in 2010 and 2011, and to elevate the return on sales before taxes compared to 2009. An economic recovery, particularly in the USA, is the precondition for this.

The complete 2009 Annual Financial Report is available at the following link: www.world-of-medicine.com/2009/annualfinancialreport/index.htm.

WORLD OF MEDICINE and its technologies are paving the way in Minimally Invasive Surgery - or MIS for short. This approach includes safe and gentle surgical procedures conducted through keyhole or puncture incisions, instead of major incisions. The Company is the global market leader in a niche of this future market.

@@start.t2@@end of announcement                                                 euro adhoc

ots Originaltext: W.O.M. World of Medicine AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Stefanie Gehrke
Cell Phone: + 49 (0) 172 402 67 40
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN:      DE0006637390
WKN:        663739
Index:    CDAX, Prime All Share, Technology All Share
Börsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              München / free trade

Weitere Meldungen: W.O.M. World of Medicine AG

Das könnte Sie auch interessieren: